NorthCrest Asset Manangement LLC Has $1.55 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

NorthCrest Asset Manangement LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,806 shares of the company’s stock after purchasing an additional 226 shares during the quarter. NorthCrest Asset Manangement LLC’s holdings in HCA Healthcare were worth $1,547,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. NorthRock Partners LLC boosted its holdings in HCA Healthcare by 17.4% during the first quarter. NorthRock Partners LLC now owns 1,310 shares of the company’s stock valued at $437,000 after acquiring an additional 194 shares during the period. New Mexico Educational Retirement Board grew its holdings in HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after buying an additional 3,200 shares during the last quarter. LVW Advisors LLC lifted its holdings in shares of HCA Healthcare by 76.4% during the first quarter. LVW Advisors LLC now owns 3,189 shares of the company’s stock worth $1,064,000 after buying an additional 1,381 shares during the last quarter. Aviance Capital Partners LLC acquired a new stake in shares of HCA Healthcare in the first quarter worth $2,543,000. Finally, Financial Strategies Group Inc. boosted its holdings in HCA Healthcare by 12.8% in the 1st quarter. Financial Strategies Group Inc. now owns 16,289 shares of the company’s stock valued at $5,357,000 after purchasing an additional 1,844 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at $3,436,623.54. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,345 shares of company stock worth $5,747,945 over the last three months. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, Oppenheimer increased their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, twelve have given a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $377.17.

HCA Healthcare Price Performance

Shares of HCA stock opened at $363.55 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a market capitalization of $93.82 billion, a price-to-earnings ratio of 17.07, a PEG ratio of 1.52 and a beta of 1.67. The firm’s 50 day moving average is $395.06 and its 200-day moving average is $352.71. HCA Healthcare, Inc. has a 1 year low of $220.55 and a 1 year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. HCA Healthcare’s payout ratio is currently 12.39%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.